Integer Holdings Co. (NASDAQ:ITGR)’s share price rose 6.1% during mid-day trading on Monday . The company traded as high as $23.60 and last traded at $23.56, with a volume of 662,339 shares changing hands. The stock had previously closed at $22.21.

ITGR has been the topic of a number of recent analyst reports. Sterne Agee CRT reaffirmed a “buy” rating on shares of Integer Holdings in a research report on Monday, May 16th. Zacks Investment Research raised Integer Holdings from a “sell” rating to a “hold” rating in a research report on Thursday, May 19th. Finally, TheStreet lowered Integer Holdings from a “hold” rating to a “sell” rating in a research report on Friday, July 1st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $57.00.

The stock’s market cap is $704.87 million. The stock’s 50 day moving average is $0.00 and its 200-day moving average is $0.00.

Integer Holdings (NASDAQ:ITGR) last issued its earnings results on Thursday, July 28th. The company reported $0.56 earnings per share for the quarter, missing the consensus estimate of $0.70 by $0.14. During the same quarter in the prior year, the firm posted $0.73 earnings per share. The business earned $348.38 million during the quarter, compared to the consensus estimate of $356.72 million. Integer Holdings’s revenue was up 99.2% on a year-over-year basis. On average, equities research analysts predict that Integer Holdings Co. will post $3.12 earnings per share for the current year.

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.